TOP 100:
News on
in
for

Health & Beauty

November 28, 2014 18:46
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: As per November 28, 2014, the total number of shares in Vitrolife AB (publ)(STO:VITR) amounts to 21,710,115, of which Vitrolife itself holds 0 shares. The share capital amounts to SEK 22,144,317.30. At the beginning of the month the total number...
World  World      Medical Devices  Medical Devices
November 28, 2014 18:23
CHESHIRE, Connecticut--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) ha anunciado que el Comité de Evaluación de Tecnologías Altamente Especializadas del NICE (National Institute for Health and Care Excellence) ha recomendado que Soliris® (eculizumab) se ponga en servicio para todo...
World  World      Biotechnology  Biotechnology
November 28, 2014 18:09
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/lsgsqc/otc) has announced the addition of the "OTC Pharmaceuticals: Global Group of Eight (G8) Industry Guide" report to their offering. The G8 OTC Pharmaceuticals industry guide provides top-line qualitativ...
World  World      Pharmaceutical  Pharmaceutical
November 28, 2014 18:03
GARDEN CITY, Nueva York--(BUSINESS WIRE)--ImaCor, Inc., desarrollador de la primera y única tecnología de ecocardiografía transesofágica hemodinámica (hTEE™) del mundo, ha anunciado el lanzamiento de su plataforma todo en uno para la gestión hemodinámica avanzada. Además, ImaCor ha conseguido la ...
World  World      Biotechnology  Biotechnology
November 28, 2014 18:03
GARDEN CITY, N.Y.--(BUSINESS WIRE)--ImaCor, Inc., ontwikkelaar van 's werelds eerste en enige hemodynamische, transoesofagale echocardiografische technologie, heeft donderdag zijn alles-in-een-platform voor geavanceerd management van de bloedsomloop gepresenteerd. ImaCor heeft bovendien van de Am...
World  World      Biotechnology  Biotechnology
November 28, 2014 17:45
TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV: ATE) filed its financial and operating results today for its fiscal quarter ended September 30, 2014. Highlights for the quarter include: The Company completed the first stage of its Phase I study, the presc...
World  World      Biotechnology  Biotechnology